Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million on October 15, 2014. Wang Shiduo will transfer 0.47% stake in Changchun Changsheng to Wang Lining for CNY 12.15 million; Xu Lei will transfer 0.24% stake in Changchun Changsheng to Wang Lining for CNY 6.25 million; Chen Gu will transfer 0.06% stake in Changchun Changsheng to Wang Lining for CNY 1.5 million. Changchun Changsheng Life Sciences Limited reported total assets of CNY 1.56 billion, total owner's equity of CNY 1 billion, revenue of CNY 622.62 million, operating profit of CNY 236.68 million and net profit of CNY 207.86 million as of December 31, 2014.
End-of-day quote
Other stock markets
|
||
- CNY | - |
1st Jan change | Capi. | |
---|---|---|
0.00% | 106M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 002680 Stock
- News Changsheng Bio-technology Co Ltd
- Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million.